scholarly article | Q13442814 |
P50 | author | Ruth Pfeiffer | Q90909936 |
Claudia Bessa Pereira Chaves | Q90736926 | ||
P2093 | author name string | Marcelo A Soares | |
Eric A Engels | |||
Anna E Coghill | |||
Anke Bergmann | |||
Esmeralda A Soares | |||
Claudia B Chaves | |||
Luiz C Thuler | |||
Mariana P Ferreira | |||
P2860 | cites work | Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer | Q27860857 |
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma | Q27861062 | ||
Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials | Q33383729 | ||
Patterns of care for women with cervical cancer in the United States | Q33789524 | ||
Effectiveness of potent antiretroviral therapies on the incidence of opportunistic infections before and after AIDS diagnosis | Q33939861 | ||
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis | Q34580943 | ||
Contribution of HIV infection to mortality among cancer patients in Uganda | Q35056551 | ||
The Global Burden of Cancer 2013 | Q35847426 | ||
Elevated Cancer-Specific Mortality Among HIV-Infected Patients in the United States | Q35847460 | ||
Survival among HIV-infected and HIV-uninfected individuals with common non-AIDS-defining cancers | Q35921020 | ||
Risk of human papillomavirus-associated cancers among persons with AIDS. | Q37309962 | ||
Human papillomavirus, human immunodeficiency virus and immunosuppression | Q38064064 | ||
Melanoma Outcomes in Transplant Recipients With Pretransplant Melanoma. | Q40052413 | ||
Paving pathways: Brazil's implementation of a national human papillomavirus immunization campaign | Q40905325 | ||
Cancer risk in people infected with human immunodeficiency virus in the United States | Q45395561 | ||
Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study | Q56837790 | ||
Why are women with cervical cancer not being diagnosed in preinvasive phase? An analysis of risk factors using a hierarchical model | Q83463589 | ||
[Determinants of late stage diagnosis of cervical cancer in Brazil] | Q87515234 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cervix uterine cancer | Q160105 |
P304 | page(s) | 523-531 | |
P577 | publication date | 2017-02-01 | |
P1433 | published in | AIDS | Q4651863 |
P1476 | title | Outcomes of cervical cancer among HIV-infected and HIV-uninfected women treated at the Brazilian National Institute of Cancer | |
P478 | volume | 31 |
Q91725648 | Advanced stage at diagnosis and elevated mortality among US patients with cancer infected with HIV in the National Cancer Data Base |
Q38640490 | Cervical cancer control in HIV-infected women: Past, present and future. |
Q56941300 | Detection of hypermethylated genes as markers for cervical screening in women living with HIV |
Q90569292 | Effects of HIV status on non-metastatic cervical cancer progression among patients in Lusaka, Zambia |
Q57172787 | Evolving Paradigms in HIV Malignancies: Review of Ongoing Clinical Trials |
Q91335035 | Five-year overall survival following chemoradiation among HIV-positive and HIV-negative patients with locally advanced cervical carcinoma in a South African cohort |
Q52605454 | Impact of Human Immunodeficiency Virus Infection on Survival and Acute Toxicities From Chemoradiation Therapy for Cervical Cancer Patients in a Limited-Resource Setting. |
Q92314980 | The association between HIV infection and cervical cancer presentation and survival in Uganda |
Q91813495 | Treatment of pre- and confirmed cervical cancer in HIV-seropositive women from developing countries: a systematic review |
Search more.